Switching to Aflibercept in Diabetic Macular Edema after Unsatisfactory Response to Other Anti-vascular Endothelial Growth Factor Drugs
Walid S. Ibrahim, Zeiad H. Eldaly, Mohamed G. Saleh, Mahmoud F. Rateb, Ahmed H. Aldoghaimy
Korean J Ophthalmol. 2019;33(2):122-130.   Published online 2019 Apr 8     DOI: https://doi.org/10.3341/kjo.2018.0037
Citations to this article as recorded by Crossref logo
Review of clinical studies and recommendation for a therapeutic flow chart for diabetic macular edema
Shigeo Yoshida, Tomoaki Murakami, Miho Nozaki, Kiyoshi Suzuma, Takayuki Baba, Takao Hirano, Osamu Sawada, Masahiko Sugimoto, Yoshihiro Takamura, Eiko Tsuiki
Graefe's Archive for Clinical and Experimental Ophthalmology.2021; 259(4): 815.     CrossRef
PF4 antagonizes retinal neovascularization via inhibiting PRAS40 phosphorylation in a mouse model of oxygen-induced retinopathy
Siwei Cai, Qianhui Yang, Yunshan Cao, Yahong Li, Juping Liu, Jiantao Wang, Xiaomin Zhang, Liren Liu, Xiaorong Li, Yan Zhang
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2020; 1866(3): 165604.     CrossRef
Anti-VEGF agents in the management of diabetic macular edema
Angela S. Li, Malini Veerappan, Vaishali Mittal, Diana V. Do
Expert Review of Ophthalmology.2020; 15(5): 285.     CrossRef